Karina Billiris Findlay, MD, FACS CURRICULUM VITAE

Retina Vitreous Associates of Florida
Tampa, FL
July 1, 1998- June 30, 2000

Retina Vitreous Associates of Florida
Medical and Surgical Vitreoretinal Fellowship
Tampa, FL
July 1, 1997- June 30, 1998

University of South Florida
Department of Ophthalmology
Tampa, FL
1994-1997

University of South Florida
Department of Internal Medicine
Tampa, FL
1993-1994

University of South Florida
College of Medicine
Tampa, FL
Degree: Doctor of Medicine
1989-1993

University of South Florida
Tampa, FL
B.A. Chemistry, Summa Cum Laude
1987-1989

St. Petersburg Junior College
A.A., High Honors
1985-1987

Castle Connolly Top Doctors 2021
Best Doctors in America 2019-2020
Florida Top Doctor 2018-2022
America’s Top Ophthalmologists, 2007
Strathmore’s Who’s Who in America, 2007
National Register’s Who’s Who in Executives and Professionals, 2005-2006
Alpha Omega Alpha Honor Medical Society
Southern Medical Assn. Medical Student Scholarship Award, 1990
Vice President, Medical School Class of 1993
Honor Society of Phi Kappa Phi
Golden Key National Honor Society
Dean’s List for the College of Natural Sciences, 1987-1989
Award for Superior Academic Achievement, 1987-1988
St. Petersburg Jr. College Alumni Apollo Award, Finalist 1987
Transfer Student Scholarship Award, 1987
Florida Blue Key Community College Leadership Award, 1987
Phi Theta Kappa National Honor Society
Chapter President of Phi Theta Kappa, 1986-1987
Who’s Who Among Students in American Junior Colleges, 1985

Clinical Associate Professor
University of South Florida
Department of Ophthalmology
Tampa, FL
August 1, 2011 to present

Affiliate Assistant Professor
University of South Florida
Department of Ophthalmology
Tampa, FL
August 1, 2004 to July 31, 2011

Clinical Assistant Professor
University of South Florida
Department of Ophthalmology
Tampa, FL
August 1, 1998 to July 31, 2004

Diplomate, National Board of Medical Examiners, 1994
Diplomate, American Board of Ophthalmology, 1998, 2008, 2018
Fellow, American Academy of Ophthalmology, 1998
Fellow, American College of Surgeons, 2001

American Academy of Ophthalmology
American College of Surgeons
American Medical Association
Florida Medical Association
Hillsborough County Medical Association
Florida Society of Ophthalmology
Tampa Bay Ophthalmological Society
American Society of Retinal Specialists
Association for Research in Vision and Ophthalmology
Research to Prevent Blindness
American Diabetes Association

AdventHealth Tampa (Active)

2018- present Monthly Case Conferences
Tampa General Hospital
USF Department of Ophthalmology

2020 “Retinal Physiology and Psychophysics; Congenital and Stationary Retinal Disease”
USF Resident Lecture, Department of Ophthalmology
University of South Florida College of Medicine
Tampa, FL

2018 “Drug Induced Retinal Toxicity”
USF Resident Lecture, Department of Ophthalmology
University of South Florida College of Medicine
Tampa, FL

2016-2018: Attending Physican, James A. VA Hospital
Seeing patients and staffing cases with residents in the eye clinic
Tampa, FL

1998-2015: Attending Physician, James A. Haley VA Hospital
Attending surgical cases with residents and fellows once monthly
Tampa, FL

2011 “Diseases of the Vitreous”
USF Resident Lecture, Department of Ophthalmology
University of South Florida College of Medicine
Tampa, FL

2011, 2010 “Diabetic Retinopathy”
St. Joseph’s Hospital
Patient Education
Tampa, FL

2006 “Diabetic Retinopathy”
University Community Hospital
Diabetes educators
Tampa, FL

2005 “Diabetic Retinopathy”
University Community Hospital
Patient education
Tampa, FL

2003 “Age-Related Macular Degeneration- New and Promising Treatments”
Hillsborough Society of Optometrists
Brandon, FL

2002 “Age-related Macular Degeneration”
Rotary Club Luncheon
Tarpon Springs, FL

1998 “Diabetic Retinopathy”
Helen Ellis Memorial Hospital
Patient education
Tarpon Springs, FL

1998 “Effects of Electromagnetic Energy on the Retina”
USF Resident Lecture, Department of Ophthalmology
University of South Florida College of Medicine
Tampa, FL

Kodiak Sciences KSI-301: A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants with Diabetic Macular Edema (DME) (GLEAM), Investigator

Chengdu Kanghong Biotechnology KHB-1801: A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Conbercept Intravitreal Injection in Subjects with Neovascular Age-related Macular Degeneration (PANDA), Investigator

Opthea OPT-302-1002: A Dose-Ranging Study of Intravitreal OPT-302 in Combination with Ranibizumab, Compared with Ranibizumab Alone, in Participants with Neovascular Age-related Macular Degeneration, Deputy Principal Investigator

Clearside Biomedical: A Randomized, Masked, Controlled Trial to Study the Safety and Efficacy of Suprachoroidal CLS-TA in Conjunction with Intravitreal Aflibercept in Subjects with Retinal Vein Occlusion (SAPPHIRE), Deputy Principal Investigator

Allergan: Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-Related Macular Degeneration (SEQUOIA), Investigator

Hoffmann- La Roche Protocol BP29647: A Multiple-Center, Multiple Dose and Regimen, Randomized, Active Comparator Controlled, Double-Masked, Parallel Group, 36 week Study to Investigate the Safety, Tolerability, Pharmacokenetics, and Efficacy of RO6867461 Administered Intravitreally in Patients with Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AVENUE), Investigator

Hoffmann-La Roche Protocol BP30099: A Multiple-Center, Multiple-Dose, Randomized, Active Comparator-Controlled, Double-Masked, Parallel Group, 28- Week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients with Diabetic Macular Edema (BOULEVARD), Investigator

Genentech/Roche Protocol GX29185: Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Efficacy and Safety of Lampalizumab Administered Intravitreally to Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration, Investigator

Alcon: Efficacy and Safety of RTH258 vs. Aflibercept (HAWK), Investigator

Allergan: A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration (BEACON), Investigator

TOGA: Treatment with Oracea for Geographic Atrophy: Phase 2/3 Study Evaluating the Safety and Efficacy of Daily Oral Administration of Doxycycline (ORACEA) vs. Placebo in Subjects with Geographic Atrophy, Investigator, 2014-2016

Thrombogenics Protocol TG-MV-018: Ocriplasmin Research to Better Inform Treatment (ORBIT) Phase 4 Trial, Investigator, 2014-2016

Pautler, S, Cohen S, Billiris Findlay K, Eichenbaum D, Lopez, M. Clinical Findings of the Posterior Uveal Effusion Syndrome. American Academy of Ophthalmology, November 2015 (Poster)

Eichenbaum D, Cohen S, Pautler S, Billiris-Findlay K. A Prospective Study of Ranibizumab for DME: Monthly Injections vs. Treat-and-Extend. Toronto: American Society of Retinal Specialists, August 2013 (Poster)

Topical Lidocaine Gel with and without Subconjunctival Lidocaine Injection for Intravitreal Injection, Sub-Investigator, 2012-2013

Phase III Safety and Efficacy Study of Vitrase (Hyaluronidase) for Ophthalmic Intravitreal Injection for Clearance of Severe Vitreous Hemorrhage Study #VIT-02-08961X

Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) Co-Principal investigator (1998-2001)

PUBLICATIONS:

Cohen SM, Billiris-Findlay K, Eichenbaum DA, Pautler SE. Topical Lidocaine Gel With and Without Subconjunctival Lidocaine Injection for Intravitreal Injection: A Within-Patient Study. OSLI Retina 2014; 45(4): 306-310

Davis A, Cohen SM, Pautler SE, Billiris-Findlay K, Eichenbaum DA. Beta Blocker Use and Age-Related Macular Degeneration. Acta Ophthalmologica, 2012; 90: 232-233

Complications of Age-Related Macular Degeneration Prevention Trial Research Group. Laser Treatment in Patients with Bilateral Large Drusen: The Complications of Age-Related Macular Degeneration Prevention Trial. Ophthalmology 2006; 113:1974-1986

The Complications of Age-Related Macular Degeneration Prevention Trial Research Group. Baseline Characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and Their Associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT). Ophthalmology 2004; 111(7):1307-16

The Complications of Age-Related Macular Degeneration Prevention Trial Research Group. The Complications of Age-Related Macular Degeneration Trial (CAPT): rational, design and methodology. Clinical Trials. 2004; 1(1): 91-107

Margo CE, Mula Z, Billiris KK. Incidence of Surgically Treated Uveal Melanoma by Race and Ethnicity. Ophthalmology 1998; 105:1087-1090.

Billiris KK, Pavan PR, Margo CE, et al. Unilateral Canthaxanthin Retinopathy. The Vitreous Society Online Journal d1998; 1 (2) [7 screens]. Available from: URL: http//www.vitreosociety.org

Billiris KK, Margo CE. Basal Cell Nevus Syndrome. Ophthalmic Practice 1997; 15:79-82.

Margo CE, Billiris KK. Test Chapter: Surgical Pathology of Pediatric Ophthalmology. Ophthalmic Surgery: Principles and Techniques, Dan Alpert, M.D. et al.